Pharma & Biotech
Tissue Regenix sees strong demand for product portfolio
ReNeuron encouraged by progress in stroke and RP treatments
4D pharma: A clinical stage innovator and pioneer of Live Biotherapeutics
Only registered members can use this feature.
© Proactive Investors 2021.
Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority. Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.